FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37368411000001109: Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
299241000001114 Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
299251000001112 Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Is a Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Is a Zelapar true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) 30 tablet Has AMP True Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start